(February 25, 2019, 1:30 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Feb. 21 said it concluded that there is an increased risk of death from the use of Uloric brand febuxostate to treat gout and said doctors should reserve Uloric for patients who cannot use allopurinol, an alternative gout drug....